Plasminogen activators and their inhibitors in leukemic cell homogenates-Reference-Cited by-同舟云学术

Plasminogen activators and their inhibitors in leukemic cell homogenates

Published:1993-02 Issue:2 Volume:42 Page:166-170
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Wada Hideo,Kumeda Yasurou,Ogasawara Zin,Ohiwa Michiaki,Kaneko Toshihiro,Tamaki Shigehisa,Ohno Toshiyuki,Kageyama Sinichi,Kobayashi Thoru,Deguchi Katsumi,Shirakawa Shigeru

Publisher

Wiley

Subject

Hematology

Reference16 articles.

1. Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia

2. The Fibrinolytic Enzyme System in Leukaemia, Myelomatosis and Myeloproliferative Diseases

3. : Cancer cell procoagulant activity. In (ed): “Malignancy and Hemostatic System.” New York: Raven Press, 1981, p 57.

4. Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia

5. Coagulent and fibrinolytic activities in the leukemic cell lysates

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa;Thrombosis Journal;2021-02-25

2. Thrombosis-Responsive Thrombolytic Coating Based on Thrombin-Degradable Tissue Plasminogen Activator (t-PA) Nanocapsules;Advanced Functional Materials;2017-10-10

3. Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?;Hematology;2017-08-20

4. Disseminated intravascular coagulation: Testing and diagnosis;Clinica Chimica Acta;2014-09

5. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - Safety and efficacy in 1,032 patients with hematologic malignancy;Thrombosis Research;2014-03